Thus, strategies that ensure proper CCV uncoating, for example by increasing Hsc70 availability or function, may hold promise for improving synaptic function and reducing neurodegeneration in PD and other α-synuclein-associated diseases. The gene discussed is SNCA; the disease is Parkinson disease.